NIH Funding Opportunities (Notices, PA, RFA)
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 40 min 30 sec ago
Notice of NIA Participation in PAR-20-157 "Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)"
Notice NOT-AG-20-027 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice to Extend the Response Date for NOT-DK-20-015, Request for Information: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Strategic Plan
Notice NOT-DK-20-019 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19)
Notice NOT-CA-20-042 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of An Additional Cycle of Receipt Dates Added to PAR-18-307 Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional)
Notice NOT-OD-20-093 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) Related to HIV Comorbidities, Coinfections, and Complications within NIDDK's Mission
Notice NOT-DK-20-020 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Intent to Publish a Funding Opportunity Announcement for Collaborative Partnership between on Alcohol Research Centers and Institutions serving Underserved Communities and Populations (U54 Clinical Trial Optional)
Notice NOT-AA-20-006 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): Single-Cell Proteomics for Interrogating Premalignant and Early Malignant Lesions
Notice NOT-CA-20-044 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Guidance for Cost-Related Flexibilities Available to Support of Competitive Research (SCORE) Award Recipients Affected by COVID-19
Notice NOT-GM-20-026 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Information: Change in NCATS Prior Approval Process for New CTSA Program Pilot Projects that Involve Human Subjects Research
Notice NOT-TR-20-019 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): Advancing Cancer Data Repositories and Knowledgebases
Notice NOT-CA-20-045 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities
Notice NOT-MD-20-019 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus
Notice NOT-TR-20-017 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus
Notice NOT-MH-20-047 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus
Notice NOT-TR-20-016 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): National Cancer Institute Announcement regarding Availability of Competitive Revision SBIR/STTR Supplements on Coronavirus Disease 2019 (COVID-19)
Notice NOT-CA-20-043 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): Supporting Research Education in High-Priority Intervention and Services Research Areas for Mentoring Networks for Mental Health Research Education and Short Courses for Mental Health Related Research
Notice NOT-MH-20-041 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Utilizing Cohort Studies to Address Health Outcomes in Cancer Survivors (UG3/UH3 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-20-030 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the NCI invites applications to support research in new and innovative cohort studies that identify clinical, lifestyle, genomic, and other factors that affect health outcomes (e.g., morbidity, mortality, quality of life, physical, social, and psychological outcomes) in cancer survivors. This RFA supports research that requires the creation of a new prospective cohort study of cancer survivors that addresses a gap in knowledge pertaining to the health of cancer survivors. Proposals must identify the scientific gap that the study addresses, which may include emerging treatments, less common cancer sites, and/or other understudied populations of cancer survivors with disparities. Sample size and proposed data collection must be driven by the scientific questions proposed and include information from the following five domains: 1) disease characteristics (e.g., type, stage), 2) individual survivor characteristics (e.g., comorbidities, SES, social connections, access to care measures), 3) treatment, treatment-related effects, and follow-up care (e.g. dose, adverse events, palliative care), 4) behavioral and lifestyle factors (e.g., diet, physical activity) and 5) quality of life outcomes (health related quality of life). These domains may represent exposures and/or outcomes, depending on the research questions, and should be measured at multiple timepoints, when appropriate. The UG3 Planning-Exploratory Phase focused on recruitment and data collection/utilization, and the UH3 Implementation Phase focused on completing the research agenda. Milestones to be accomplished in the UG3 phase for transition to the UH3 will be proposed by the PI, with approval by NCI, and must include a timeline for recruitment and show feasibility for data collection and analysis. Recruitment is not required to be completed in the UG3 phase, but reasonable progress should be demonstrated so that all aims will be completed in the UH3 phase.
Categories: Job Watch, Literature Watch
Notice of NCATS Withdrawal from Participation in PAR-18-691, "Innovative Therapies and Tools for Screenable Disorders in Newborns (R21 Clinical Trial Optional)
Notice NOT-TR-20-020 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of NHGRI Interest in Receiving Letters Requesting Permission to Submit Applications to Support the NHGRI Research Training and Career Development Annual Meeting (U13)
Notice NOT-HG-20-035 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Expiration of RFA-CA-19-046 "Participant Engagement and Cancer Genome Sequencing (PE-CGS): Coordinating Center (U24 Clinical Trial Not Allowed)
Notice NOT-CA-20-046 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch